PCMA Blog
ICYMI: Experts Discuss Value of PBMs at Capitol Hill Briefing
What exactly are pharmacy benefit managers (PBMs) and why are policymakers hearing so much about them now? That was one
ICYMI: Experts Discuss Value of PBMs at Capitol Hill Briefing
What exactly are pharmacy benefit managers (PBMs) and why are policymakers hearing so much about them now? That was one
PBMs Innovating to Increase Biosimilar Use, Lower Rx Costs
Big Pharma Continues to Undermine Competition, Setting High Drug Prices to Boost Profits As the House Ways and Means Subcommittee
PCMA Congratulates Dr. Mehmet Oz on His Confirmation to Lead the Centers for Medicare & Medicaid Services
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) released a statement today following the U.S. Senate confirmation of Dr.
PBMs Work to Lower the Costs of GLP-1 Drugs
PBMs are facilitating coverage of these drugs for weight management, but Big Pharma companies are still shifting blame for their
PBMs Are Breaking Down Barriers to Expand Access to Biosimilars and Lower Consumer Costs
While Drug Companies Drive Up Drug Prices with Anti-Competitive Behavior, PBMs Continue to Innovate and Lower Costs for Consumers As
PBMs Offer Innovative Cost-Sharing Programs to Address Patient Out-of-Pocket Costs
Lowering Patient Costs Leads to More Accessible and Affordable Prescription Drugs More than 92% of prescriptions cost patients less than
ICYMI: JC Scott: PBMs Evolving to Meet Consumer Needs
In a new op-ed published in RealClearHealth, JC Scott, president and CEO of the Pharmaceutical Care Management Association (PCMA), highlights how PBMs are
Sorry, no posts matched your criteria.
